Range Financial Group
CORT icon

Range Financial Group’s Corcept Therapeutics CORT Stock Holding History

Range Financial Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.28M Buy
+11,136
New +$1.2M 0.36% 91
2025
Q1 		– Sell
-21,452
Closed -$1.08M – 185
2024
Q4 		$1.08M Buy
+21,452
New +$1.12M 0.5% 63

Other funds holding CORT

KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Range Financial Group's CORT Position: Q3 2026 in Review

Range Financial Group opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 11,136 shares worth $1.28M. The stake represents 0.36% of the portfolio and ranks #91 among its holdings. This is a return to the name: Range Financial Group previously reported a position in CORT as recently as Q4 2024.

Range Financial Group first reported a position in CORT in Q4 2024 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Range Financial Group held 11,136 shares of Corcept Therapeutics worth $1.28M as of Q3 2026.
  • Corcept Therapeutics was a new Range Financial Group position in Q3 2026.
  • Corcept Therapeutics made up 0.36% of Range Financial Group's portfolio in Q3 2026, its #91 holding.
  • Range Financial Group first reported a position in Corcept Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Range Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.